Johnson & Johnson plans to break up into two companies, splitting off the $15-billion-a-year division that sells Band-Aid bandages, Tylenol medicines and Johnson’s Baby Powder in a shift indicating just how much healthcare has changed since the company helped pioneer the industry.

The world’s largest health-products company by sales will separate its high-margin but risky prescription-drugs and medical-devices business from its storied but slower-growing consumer group, creating two publicly traded companies.

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tyson Suspends Managers After Lawsuit Claims They Bet on Covid-19 Infections

Tyson Foods Inc. said it suspended managers at an Iowa pork plant…

Biden’s Minimum-Wage Proposal: When Would It Reach $15 an Hour?

A recent exchange between Republican senators and a leading proponent of raising…

Sewage spill closes multiple Southern California beaches

Southern California beaches from Orange to Los Angeles counties were closed over…

Apple to Unveil iPhone 14 Lineup

Apple on Wednesday begins a third year of nudging customers to iPhones…